The growth of medical science liaison (MSL) teams is helping pharma communicate with healthcare professionals in a more 'peer-to-peer' way, and could help improve frontline relations.
Novartis has struck another deal to build its position in radiopharmaceuticals, agreeing to pay $1 billion upfront for radioligand therapy (RLT) developer Mariana Oncology
It’s 2024, and in most clinical trials, data is still being moved from the EHR to the EDC manually – with employees reading data from one screen and typing it onto another.